175 related articles for article (PubMed ID: 8648890)
1. [Problems of the amyloid beta precursor protein in pathogenesis of the Alzheimer type dementia].
Shoji M; Hirai S
Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):164-8. PubMed ID: 8648890
[No Abstract] [Full Text] [Related]
2. [Beta/A4-type amyloid protein in Alzheimer's disease and cerebral amyloid angiopathies].
Hirai S; Okamoto K
Nihon Naika Gakkai Zasshi; 1993 Sep; 82(9):1424-9. PubMed ID: 8245639
[No Abstract] [Full Text] [Related]
3. Alzheimer's disease and amyloid.
Robertson M
Nature; 1992 Mar; 356(6365):103. PubMed ID: 1545855
[No Abstract] [Full Text] [Related]
4. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor.
Lu DC; Rabizadeh S; Chandra S; Shayya RF; Ellerby LM; Ye X; Salvesen GS; Koo EH; Bredesen DE
Nat Med; 2000 Apr; 6(4):397-404. PubMed ID: 10742146
[TBL] [Abstract][Full Text] [Related]
5. Rapid cerebral amyloid binding by Aβ antibodies infused into β-amyloid precursor protein transgenic mice.
Winkler DT; Abramowski D; Danner S; Zurini M; Paganetti P; Tolnay M; Staufenbiel M
Biol Psychiatry; 2010 Nov; 68(10):971-4. PubMed ID: 20359696
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
[TBL] [Abstract][Full Text] [Related]
7. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
Games D; Adams D; Alessandrini R; Barbour R; Berthelette P; Blackwell C; Carr T; Clemens J; Donaldson T; Gillespie F
Nature; 1995 Feb; 373(6514):523-7. PubMed ID: 7845465
[TBL] [Abstract][Full Text] [Related]
9. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase.
Yang H; Zhuo JM; Chu J; Chinnici C; Praticò D
Biol Psychiatry; 2010 Nov; 68(10):922-9. PubMed ID: 20570249
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
12. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T
J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572
[TBL] [Abstract][Full Text] [Related]
13. The 7th Leonard Berg Symposium, Part 3.
Strobel G
J Alzheimers Dis; 2010; 21(1):315-21. PubMed ID: 20657051
[No Abstract] [Full Text] [Related]
14. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
[TBL] [Abstract][Full Text] [Related]
15. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
[TBL] [Abstract][Full Text] [Related]
16. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
Querfurth HW; LaFerla FM
N Engl J Med; 2010 Jan; 362(4):329-44. PubMed ID: 20107219
[No Abstract] [Full Text] [Related]
19. [Internalization of beta amyloid protein in primary cultured cortical neurons in mouse].
Qian YH; Shi LL; Yang J; Hu XD; Han H; Liu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 33(11):1019-27. PubMed ID: 19060370
[TBL] [Abstract][Full Text] [Related]
20. Biomedicine. Tauists and beta-aptists united--well almost!
Lee VM
Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
